Levosimendan versus Dobutamine in Heart Failure Patients Treated Chronically with Carvedilol.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 3, p. 182, doi. 10.1111/j.1755-5922.2008.00050.x
- By:
- Publication type:
- Article
Works matching IS 17555914 AND DT 2008 AND VI 26 AND IP 3
Results: 7
1
2
Assessment of Arterial Stiffness, A Translational Medicine Biomarker System for Evaluation of Vascular Risk.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 3, p. 214, doi. 10.1111/j.1755-5922.2008.00051.x
- By:
- Publication type:
- Article
3
Activation of HtrA2, a Mitochondrial Serine Protease Mediates Apoptosis: Current Knowledge on HtrA2 Mediated Myocardial Ischemia/Reperfusion Injury.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 3, p. 224, doi. 10.1111/j.1755-5922.2008.00052.x
- By:
- Publication type:
- Article
4
Insulin Resistance: A Potential New Target for Therapy in Patients with Heart Failure.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 3, p. 203, doi. 10.1111/j.1755-5922.2008.00053.x
- By:
- Publication type:
- Article
5
Transcriptomics: New Targets for Diagnosing and Treating Cardiovascular Disease.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
6
Nebivolol: A Highly Selective β<sub>1</sub>-Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide.
- Published in:
- Cardiovascular Therapeutics, 2008, v. 26, n. 3, p. 189, doi. 10.1111/j.1755-5922.2008.00054.x
- By:
- Publication type:
- Article
7
Erratum.
- Published in:
- 2008
- Publication type:
- Correction Notice